Trelegy Ellipta (Fluticasone Furoate, Umeclidinium, Vilanterol)

What Is Trelegy Ellipta?

Trelegy Ellipta is a fixed-dose combination inhalation powder that delivers three active ingredients in a single device:

• Fluticasone furoate – an inhaled corticosteroid (ICS)
• Umeclidinium – a long-acting muscarinic antagonist (LAMA)
• Vilanterol – a long-acting beta₂-agonist (LABA)

This triple therapy approach targets multiple pathways involved in chronic airway disease. Trelegy Ellipta is prescribed for adults with:

• Chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
• Asthma requiring escalation to combination maintenance therapy

COPD is a progressive respiratory condition characterised by airflow limitation and chronic inflammation, as outlined in guidance from the NHS overview of COPD. Combination inhalers such as Trelegy Ellipta are recommended for patients whose symptoms are not adequately controlled with dual therapy.

How Trelegy Ellipta Works

1. Fluticasone Furoate – Reducing Airway Inflammation

Fluticasone furoate is a corticosteroid that acts locally in the lungs to suppress inflammatory responses. In COPD and asthma, persistent inflammation narrows the airways and contributes to symptoms such as breathlessness, wheeze and cough. By reducing inflammatory mediator release, fluticasone helps decrease swelling and mucus production.

2. Umeclidinium – Relaxing Bronchial Smooth Muscle

Umeclidinium is a long-acting muscarinic antagonist (anticholinergic). It blocks muscarinic receptors in the airway smooth muscle, preventing bronchoconstriction. This results in sustained bronchodilation and improved airflow.

3. Vilanterol – Long-Acting Bronchodilation

Vilanterol is a long-acting beta₂-agonist that stimulates beta receptors in the lungs, leading to smooth muscle relaxation. This enhances airway calibre and supports easier breathing throughout the day.

By combining these three mechanisms in one inhaler, Trelegy Ellipta simplifies treatment regimens and may improve adherence in suitable patients. Regulatory approval and pharmacovigilance oversight in the UK are provided by the Medicines and Healthcare products Regulatory Agency (MHRA), while European regulatory standards are maintained by the European Medicines Agency (EMA).

Who Can Use Trelegy Ellipta?

Adults with COPD

Trelegy Ellipta is indicated for adults diagnosed with COPD, including those with chronic bronchitis and emphysema, whose symptoms remain uncontrolled despite previous maintenance therapy. It may help:

• Reduce breathlessness
• Lower the frequency of exacerbations
• Improve lung function and daily activity tolerance

Adults with Asthma

For adults with asthma who require a combination inhaled corticosteroid, long-acting bronchodilator and additional bronchodilation, Trelegy Ellipta may be prescribed where clinically appropriate.

Who Should Not Use Trelegy?

• Individuals under 18 years of age
• Patients experiencing sudden acute bronchospasm
• Those with a severe allergy to milk proteins

Trelegy Ellipta is not intended for emergency relief of acute breathing difficulties.

Available Strengths

Trelegy Ellipta is supplied in two strengths. Your prescriber will determine the most appropriate option based on your clinical needs.

• 100/62.5/25 micrograms: 100 mcg fluticasone furoate, 62.5 mcg umeclidinium, 25 mcg vilanterol
• 200/62.5/25 micrograms: 200 mcg fluticasone furoate, 62.5 mcg umeclidinium, 25 mcg vilanterol

How to Use Trelegy Ellipta

Standard Dosage

The usual dose is one inhalation once daily, taken at the same time each day. Do not exceed one dose within a 24-hour period.

Using the Ellipta Device

1. Open the cover fully until a click is heard (this loads the dose).
2. Exhale fully away from the mouthpiece.
3. Place the mouthpiece between your lips and inhale steadily and deeply.
4. Hold your breath for a few seconds, then remove the inhaler and breathe out slowly.
5. Close the device.
6. Rinse your mouth with water and spit it out (do not swallow).

Rinsing reduces the risk of oral candidiasis (thrush), a potential side effect of inhaled corticosteroids.

Missed Dose Guidance

If a dose is forgotten, take the next inhalation at the usual scheduled time. Do not take a double dose to compensate for a missed inhalation.

Important Warnings and Precautions

• Not for Acute Relief: Always carry a fast-acting reliever inhaler, such as salbutamol, for sudden symptoms.
• Do Not Overuse: Use no more than once every 24 hours.
• Milk Protein Allergy: Contraindicated in patients with severe milk protein allergy.
• Pregnancy and Breastfeeding: Seek medical advice before use.

Bone Health

Long-term inhaled corticosteroid use may contribute to reduced bone mineral density. Patients at risk of osteoporosis may require monitoring.

Eye Conditions

Use with caution in individuals with glaucoma or cataracts. Regular ophthalmic review may be advised.

Infection Risk

Corticosteroids may increase susceptibility to infections, including pneumonia in COPD patients. Annual influenza vaccination is recommended in line with NHS guidance.

Possible Side Effects

Commonly reported adverse effects include:

• Headache
• Runny nose or sore throat
• Upper respiratory tract infections
• Pneumonia (particularly in COPD)
• Muscle or joint discomfort
• Cough or oral irritation

Seek urgent medical attention if you experience signs of an allergic reaction, severe breathing difficulty or facial swelling.

Trelegy Ellipta and Smoking

Smoking significantly accelerates lung damage and reduces the effectiveness of maintenance inhaler therapy. Continued tobacco use increases airway inflammation and exacerbation frequency in COPD.

Stopping smoking is the single most effective intervention to slow COPD progression. Patients are encouraged to seek support through structured smoking cessation programmes, behavioural support or pharmacotherapy where appropriate.

Storage Information

• Store in a dry place at room temperature.
• Keep out of the sight and reach of children.
• Keep the inhaler sealed in its tray until first use.

Buying Trelegy Ellipta Online

Ordering Trelegy Ellipta online from a regulated pharmacy may offer cost savings due to pricing structures and supply chain efficiencies. Patients should ensure that:

• A valid prescription is required
• The pharmacy is properly licensed and regulated
• Professional advice is available if needed

LifePath Meds offers competitive pricing to help make long-term COPD and asthma management more affordable.